NB5R2_XENLA
ID NB5R2_XENLA Reviewed; 296 AA.
AC Q5PQA4;
DT 15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT 04-JAN-2005, sequence version 1.
DT 03-AUG-2022, entry version 73.
DE RecName: Full=NADH-cytochrome b5 reductase 2;
DE Short=b5R.2;
DE EC=1.6.2.2;
GN Name=cyb5r2;
OS Xenopus laevis (African clawed frog).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX NCBI_TaxID=8355;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC TISSUE=Testis;
RG NIH - Xenopus Gene Collection (XGC) project;
RL Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
CC -!- FUNCTION: NADH-cytochrome b5 reductases are involved in desaturation
CC and elongation of fatty acids, cholesterol biosynthesis and drug
CC metabolism. {ECO:0000250}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=2 Fe(III)-[cytochrome b5] + NADH = 2 Fe(II)-[cytochrome b5] +
CC H(+) + NAD(+); Xref=Rhea:RHEA:46680, Rhea:RHEA-COMP:10438, Rhea:RHEA-
CC COMP:10439, ChEBI:CHEBI:15378, ChEBI:CHEBI:29033, ChEBI:CHEBI:29034,
CC ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.6.2.2;
CC -!- COFACTOR:
CC Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000250};
CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane
CC protein {ECO:0000305}.
CC -!- SIMILARITY: Belongs to the flavoprotein pyridine nucleotide cytochrome
CC reductase family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; BC087294; AAH87294.1; -; mRNA.
DR RefSeq; NP_001088670.1; NM_001095201.1.
DR AlphaFoldDB; Q5PQA4; -.
DR SMR; Q5PQA4; -.
DR DNASU; 495932; -.
DR GeneID; 495932; -.
DR KEGG; xla:495932; -.
DR CTD; 495932; -.
DR Xenbase; XB-GENE-1006047; cyb5r2.S.
DR OrthoDB; 1311668at2759; -.
DR Proteomes; UP000186698; Chromosome 4S.
DR Bgee; 495932; Expressed in liver and 14 other tissues.
DR GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR GO; GO:0004128; F:cytochrome-b5 reductase activity, acting on NAD(P)H; IEA:UniProtKB-EC.
DR GO; GO:0016126; P:sterol biosynthetic process; IEA:UniProtKB-KW.
DR Gene3D; 3.40.50.80; -; 1.
DR InterPro; IPR001834; CBR-like.
DR InterPro; IPR008333; Cbr1-like_FAD-bd_dom.
DR InterPro; IPR017927; FAD-bd_FR_type.
DR InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
DR InterPro; IPR039261; FNR_nucleotide-bd.
DR InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR PANTHER; PTHR19370; PTHR19370; 1.
DR Pfam; PF00970; FAD_binding_6; 1.
DR Pfam; PF00175; NAD_binding_1; 1.
DR PRINTS; PR00371; FPNCR.
DR SUPFAM; SSF52343; SSF52343; 1.
DR SUPFAM; SSF63380; SSF63380; 1.
DR PROSITE; PS51384; FAD_FR; 1.
PE 2: Evidence at transcript level;
KW FAD; Flavoprotein; Lipid biosynthesis; Lipid metabolism; Membrane; NAD;
KW Oxidoreductase; Reference proteome; Steroid biosynthesis;
KW Steroid metabolism; Sterol biosynthesis; Sterol metabolism; Transmembrane;
KW Transmembrane helix.
FT CHAIN 1..296
FT /note="NADH-cytochrome b5 reductase 2"
FT /id="PRO_0000287553"
FT TRANSMEM 2..24
FT /note="Helical"
FT /evidence="ECO:0000255"
FT DOMAIN 35..147
FT /note="FAD-binding FR-type"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00716"
FT BINDING 127..142
FT /ligand="FAD"
FT /ligand_id="ChEBI:CHEBI:57692"
FT /evidence="ECO:0000250"
FT BINDING 166..201
FT /ligand="FAD"
FT /ligand_id="ChEBI:CHEBI:57692"
FT /evidence="ECO:0000250"
SQ SEQUENCE 296 AA; 32664 MW; BC391EEE22573505 CRC64;
MLVALAAIGV TVLLFLIKAL GSGAKKAPVT LLDPNAKYPL PLIEKQEISH DTKKFRFGLP
SAEHVLGLPV GQHIYLSAKV NGSLVVRAYT PVSSDEVKGH VDLVVKVYYK NVNPKFPDGG
KMSQHLDSLK IGETIDFRGP NGLLVYKGKG KFAIRPDKKA EPKIKVAKHV GMLAGGTGIT
PMLQLIRQIT QDPNDNTKCY LIFANQTEDD ILLRYELETV AKSHPEQFKL WYTLDRPPQG
WKYGSGFVTA DMIKEHLPPP SEDVLVLMCG PPPMIQFACQ DNLTKLGYPE AGRFAY